- Home
- BCG vs CCEL Comparison
BCG vs CCEL Comparison
Compare BCG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- CCEL
- Stock Information
- Founded
- BCG 2016
- CCEL 1989
- Country
- BCG United States
- CCEL United States
- Employees
- BCG N/A
- CCEL N/A
- Industry
- BCG
- CCEL Managed Health Care
- Sector
- BCG
- CCEL Health Care
- Exchange
- BCG Nasdaq
- CCEL Nasdaq
- Market Cap
- BCG 54.3M
- CCEL 53.9M
- IPO Year
- BCG N/A
- CCEL 1997
- Fundamental
- Price
- BCG $2.87
- CCEL $6.49
- Analyst Decision
- BCG
- CCEL
- Analyst Count
- BCG 0
- CCEL 0
- Target Price
- BCG N/A
- CCEL N/A
- AVG Volume (30 Days)
- BCG 10.6K
- CCEL 3.9K
- Earning Date
- BCG 08-15-2024
- CCEL 10-18-2024
- Dividend Yield
- BCG N/A
- CCEL N/A
- EPS Growth
- BCG N/A
- CCEL N/A
- EPS
- BCG N/A
- CCEL N/A
- Revenue
- BCG $161,897,000.00
- CCEL $31,641,636.00
- Revenue This Year
- BCG N/A
- CCEL $3.70
- Revenue Next Year
- BCG N/A
- CCEL $10.57
- P/E Ratio
- BCG N/A
- CCEL N/A
- Revenue Growth
- BCG N/A
- CCEL 1.93
- 52 Week Low
- BCG $2.50
- CCEL $3.67
- 52 Week High
- BCG $16.61
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- BCG N/A
- CCEL 50.57
- Support Level
- BCG N/A
- CCEL $6.29
- Resistance Level
- BCG N/A
- CCEL $6.80
- Average True Range (ATR)
- BCG 0.00
- CCEL 0.33
- MACD
- BCG 0.00
- CCEL 0.03
- Stochastic Oscillator
- BCG 0.00
- CCEL 32.04
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.